Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

ETR/FME stock hub

ETR/FME has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/FMEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/FME

In the news

Latest news · ETR/FME

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E28.8

P25 12.3P50 15.7P75 20.2

Trailing P/E11.3

P25 16.4P50 20.9P75 30.4

ROE7.9

P25 -6.7P50 8.5P75 17.2

ROIC6.2

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/FME market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

EUR

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	108,165
Employees Change	-3,870%
Employees Change Percent	-3.45
Enterprise value	EUR 20.8B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	DE0005785802
Last refreshed	2026-05-10
Market cap	EUR 10B
Price	EUR 37.34
Price currency	EUR
Rev Per Employee	178,970.05x
Sector	Healthcare
Sic	8090
Symbol	etr/FME
Website	https://www.freseniusmedicalcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.42%
EV Earnings	22.01x
EV/EBIT	10.2x
EV/EBITDA	6.1x
EV/FCF	11.65x
EV/Sales	1.07x
FCF yield	17.8%
Forward P/E	28.76x
P/B ratio	0.71x
P/E ratio	11.34x
P/S ratio	0.52x
PE Ratio10 Y	18.03x
PE Ratio3 Y	19.76x
PE Ratio5 Y	18.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.63%
EBITDA Margin	13.39%
FCF margin	9.22%
Gross margin	25.95%
Gross Profit	EUR 5B
Gross Profit Growth	5.4%
Gross Profit Growth Q	-0.38%
Gross Profit Growth3 Y	1.05%
Gross Profit Growth5 Y	-1.27%
Net Income	EUR 944.7M
Net Income Growth	52.82%
Net Income Growth Q	-22.28%
Net Income Growth Years	2%
Net Income Growth3 Y	16.18%
Net Income Growth5 Y	-3.53%
Pretax Margin	7.59%
Profit Margin	4.88%
Profit Per Employee	EUR 8,734
Profitable Years	26
ROA	3.63
Roa5y	3.11
ROCE	7.53
ROE	7.85
Roe5y	6.59
ROIC	6.25
Roic5y	4.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.87%
Cagr15y	-0.38%
Cagr1y	-23.72%
Cagr20y	2.64%
Cagr3y	-1.5%
Cagr5y	-8.1%
Div CAGR10	6.42%
Div CAGR3	9.98%
Div CAGR5	-10.12%
EPS Growth	56.34
EPS Growth Q	-17.15
EPS Growth Years	2
EPS Growth3 Y	17.13
EPS Growth5 Y	-3.13
FCF Growth	4.38%
FCF Growth Q	115.78%
FCF Growth3 Y	7.24%
FCF Growth5 Y	-9.26%
OCF Growth	13.36%
OCF Growth Q	39.35%
OCF Growth10 Y	6.29%
OCF Growth3 Y	8.46%
OCF Growth5 Y	-6.57%
Revenue Growth	-0.69x
Revenue Growth Q	-5.52x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.33x
Revenue Growth5 Y	1.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.6
Assets	EUR 31.5B
Cash	EUR 1.2B
Current Assets	EUR 8.1B
Current Liabilities	EUR 6.7B
Debt	EUR 11B
Debt EBITDA	EUR 3.41
Debt Equity	EUR 0.78
Debt FCF	EUR 6.19
Equity	EUR 14.2B
Interest Coverage	4.88
Liabilities	EUR 17.3B
Long Term Assets	EUR 23.4B
Long Term Liabilities	EUR 10.5B
Net Cash	EUR -9.8B
Net Cash By Market Cap	EUR -97.77
Net Debt EBITDA	EUR 3.78
Net Debt Equity	EUR 0.69
Net Debt FCF	EUR 5.49
Tangible Book Value	EUR -1.9B
Tangible Book Value Per Share	EUR -6.89
WACC	5.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.2
Inventory Turnover	6.54
Net Working Capital	EUR 2.5B
Quick ratio	0.74
Working Capital	EUR 1.4B
Working Capital Turnover	EUR 9.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.31%
Dividend Growth	3.47%
Dividend Growth Years	2%
Dividend per share	EUR 1.49
Dividend Years	29
Dividend Yield	3.99%
Ex Div Date	2026-05-22
Last Dividend	EUR 1.49
Payout Frequency	Annual
Payout Ratio	44.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-39.32%
1Y total return	-23.7%
200-day SMA	41.23
3Y total return	-4.43%
50-day SMA	38.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-34.43%
All Time High	93.82
All Time High Change	-60.2%
All Time High Date	2018-02-01
All Time Low	6.66
All Time Low Change	460.66%
All Time Low Date	2002-09-24
ATR	1.12
Beta	0.82
Beta1y	0.38
Beta2y	0.38
Ch YTD	-8.39
High	38
High52	54.02
High52 Date	2025-05-21
High52ch	-30.88%
Low	36.96
Low52	34.57
Low52 Date	2026-05-05
Low52ch	8.01%
Ma50ch	-4.02%
Price vs 200-day SMA	-9.44%
RSI	44.23
RSI Monthly	42.26
RSI Weekly	39.01
Sharpe ratio	-1x
Sortino ratio	-1.01
Total Return	6.3%
Tr YTD	-8.39
Tr15y	-5.61%
Tr1m	-4.53%
Tr1w	-3.94%
Tr3m	-8.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.9B
Operating Income Growth	19.5
Operating Income Growth Q	-1.62
Operating Income Growth3 Y	7.14
Operating Income Growth5 Y	-4.05
Operating margin	9.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	184,688,287%
Net Borrowing	212,287,000
Shares Insiders	0.04%
Shares Institutions	47.52%
Shares Out	268,564,630
Shares Qo Q	-3.73%
Shares Yo Y	-2.31%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.8B
Average Volume	888,686.5x
Bv Per Share	49.03
CAPEX	EUR -959.7M
Ch10y	-50.03
Ch15y	-27.24
Ch1m	-4.53
Ch1w	-3.94
Ch1y	-25.79
Ch20y	20.19
Ch3m	-8.12
Ch3y	-12
Ch5y	-42.23
Ch6m	-9.81
Change	0.38%
Change From Open	0.65
Close	37.2
Days Gap	-0.27
Depreciation Amortization	728,498,000
Dollar Volume	37,586,257.3
Earnings Date	2026-05-05
EBIT	EUR 1.9B
EBITDA	EUR 2.6B
EPS	EUR 3.29
F Score	7
FCF	EUR 1.8B
FCF EV Yield	8.59x
FCF Per Share	EUR 6.65
Financing CF	-1,700,505,000
Fiscal Year End	December
Founded	1,996
Goodwill	13,845,845,000
Graham Number	64.69931
Graham Upside	73.27
Income Tax	EUR 302.7M
Investing CF	-783,768,000
Is Primary Listing	1
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2007-06-18
Last Split Type	Forward
Lynch Fair Value	EUR 17.59
Lynch Upside	-52.9
Ma150	40.6
Ma150ch	-8.02%
Ma20	38.57
Ma20ch	-3.19%
Net CF	160,456,000
Next Earnings Date	2026-08-04
Open	37.1
P FCF Ratio	5.62
P OCF Ratio	3.65
Payment Date	2026-05-27
Position In Range	36.54
Ppne	6,443,302,000
Price Date	2026-05-08
Price EBITDA	EUR 3.87
Relative Volume	1.2x
Revenue	19,358,295,000x
Tax By Revenue	1.56x
Tax Rate	20.6%
Tr20y	68.41%
Tr6m	-9.81%
Volume	1,006,595
Z Score	1.84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/FME dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.0%

$1.49 annual per share

Payout ratio

+44.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-10.1%

2 consecutive years of growth

Total shareholder yield

+6.3%

Next ex-dividend date: 2026-05-22

Performance

ETR/FME stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/FME?

Insider, institutional, and short-interest positioning.

Institutional ownership

+47.5%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.3%

Negative means the company is buying back shares.

Technical

ETR/FME momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.2

Neutral momentum band

Price vs 200-day MA

-9.4%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

-1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/FME

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/FME stock rating?

etr/FME is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/FME analysis?

The full report lives at /stocks/etr/FME/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/FME?

The latest report frames etr/FME around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/FME page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.